drugs
-
Over the counter heartburn drug Zantac pulled in US, Canada
Potentially cancer-causing chemical had been detected at low levels in prescription and over-the-counter versions of Zantac.
-
Retail giant Walmart halts sales of Zantac and related drugs
Health regulators warned about a potentially dangerous contaminant in the drug.
-
US to set up plan allowing prescription meds from Canada
A step toward fulfilling a 2016 campaign promise by President Donald Trump.
-
Canadian gets death penalty as China sentences 6 foreigners for drugs
Sentence is likely to further strain Sino-Canadian relations, frayed since Meng arrest last December.
-
The high cost of drugs: take the strain off company plans
Save with tighter health benefit controls.
-
Pfizer to build new facility, add 450 jobs in Michigan
To spend $465 million building a new facility in Portage: production starting in 2024.
-
Drug developers warn Ottawa that excessive cuts to prices could be harmful
They’re nervous about changes Health Canada will propose for the Patented Medicine Prices Review Board under a review.
-
200 kgs of hash found in shipment of chocolate bars in Halifax
Mississauga, Ont., man faces multiple drug and importation charges.
-
Marijuana on the job: time to update your alcohol and drug policies
Prepare for workplace issues related to the medical and recreational use of marijuana.
-
Jean Coutu hopes a Quebec deal with drug makers will avoid tendering
Generic manufacturers fear lost business if others win exclusive rights to distribute blockbuster generic drugs.
-
Covering ‘essential’ drugs could fill health gaps, save billions
Study shows the essential medications account for 44% of prescriptions written across Canada
-
Cannabis industry opposes call for plain packaging, advertising bans
But licensed producers argue that cannabis isn’t as dangerous as tobacco.
-
WSIB posts searchable drug formularies for ease of use
Compensation board spends approximately $62 million every year on drug benefits for injured workers
-
Eli Lilly and Co. plans $70M research facility expansion
Construction is expected to be completed in 2017.
-
Valeant to cut all ties with Philidor
Hopes to minimize disruption for patients .
